Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
The purpose of this study is to learn more about what makes related and unrelated bone marrow, blood stem cell, and umbilical cord blood transplants succeed. Samples and medical information will also be collected for use in future research studies.
The conditions studied in this trial will be any malignant or non-malignant blood disorder.
Participants must weigh at least 22 pounds and be about to receive their first bone marrow, blood stem cell, or umbilical cord blood transplant.
01 - 99
Healthy Volunteers Needed
Duration of Participation
Participants will be in this study for up to two years after transplant.
Knight Clinical Trials Office Information Line
The National Institutes of Health (NIH) is sponsoring this study by providing financial support through the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)